PPCB
Propanc Biopharma (PPCB)
$71
About Propanc Biopharma (PPCB)
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
Details
Daily high
$0.74
Daily low
$0.70
Price at open
$0.72
52 Week High
$145.46
52 Week Low
$0.70
Market cap
9.5M
Dividend yield
0.00%
Volume
2,458
Avg. volume
270,056
P/E ratio
-.02
Propanc Biopharma News
Details
Daily high
$0.74
Daily low
$0.70
Price at open
$0.72
52 Week High
$145.46
52 Week Low
$0.70
Market cap
9.5M
Dividend yield
0.00%
Volume
2,458
Avg. volume
270,056
P/E ratio
-.02